Human papillomavirus (HPV) is the most common sexually transmitted infection. The
implementation of primary prevention aims to reduce the burden of HPV infection and HPV …

The discovery that the Human PapillomaVirus (HPV) is the necessary cause of cervical
cancer has led to the development of prophylactic vaccines. Cervical cancer is the second …

Human papilloma virus (HPV) is a viral agent whose transmission occurs mainly by sexual
means. It causes different pathological conditions in both males and females, ranging from …

Human papillomavirus (HPV) is the most common sexually transmitted infection and is
responsible for 90–99% of cervical cancer (CxCa) cases. Although effective screening …

Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide.
Primary prevention thorough vaccination si able to reduce the burden of HPV-related …

Human papillomavirus (HPV) related cervical cancer represents an issue of public health
priority. The World Health Organization recommended the introduction of HPV vaccination in …

Worldwide, cervical cancer is the second most common cancer of women. Less-developed
countries bear the greatest burden in terms of morbidity and mortality, largely due to the lack …

Human papillomavirus (HPV) infection is common and causes a wide spectrum of disease.
With recent advances in the development of prophylactic HPV vaccines, it is likely that these …

Human papillomavirus (HPV) related disease remains a major cause of morbidity and
mortality worldwide. Prophylactic vaccines have been recognized as the most effective …

Objective To provide guidelines for health-care providers on strategies for cervical cancer
prevention based on HPV testing and anti-HPV vaccination. Outcomes Overall efficacy of …